Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript
Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44.
Fulcrum Therapeutics Inc. (FULC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 11,609,704 | $78,365,502 | 1.22% | |
| 2. | Suvretta Capital Management Aaron Cowen | 5,518,881 | $37,252,447 | -4% | 1.68% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 1,506,422 | $10,168,349 | -38% | 0.02% |
| 4. | Leucadia National Ian Cumming And Joseph Steinberg | 1,433,316 | $9,674,883 | 0.06% | |
| 5. | Citadel Investment Group Ken Griffin | 1,403,873 | $9,476,143 | +12% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.35 | 43,360 | 43,360 | 2024-03-04 | Filing | ||
| $13.00 | 1,923,076 | Large Shareholder | 11,609,704 | 2023-01-20 | Filing | |
| $7.80 | 58,369 | Large Shareholder | 9,686,628 | 2023-01-04 | Filing | |
| $7.03 | 122,334 | Large Shareholder | 9,628,259 | 2023-01-04 | Filing | |
| $5.99 | 4,089 | Large Shareholder | 9,505,925 | 2022-12-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.72 | 4,884 | 11,807 | 2024-03-08 | Filing | ||
| $3.31 | 210 | 15,992 | 2023-05-10 | Filing | ||
| $15.00 | 6,766 | Officer, Director | 499,864 | 2023-01-13 | Filing | |
| $8.09 | 71,435 | Director | 506,630 | 2022-06-07 | Filing | |
| $8.10 | 24,382 | Director | 506,630 | 2022-06-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,684,615 | $38,371,151 | 0% | |
| 2. | 5,469,956 | $36,922,203 | 0.57% | |
| 3. | 3,473,934 | $23,449,054 | 1.53% | |
| 4. | 2,519,984 | $17,009,892 | 0% | |
| 5. | 2,343,154 | $15,816,290 | 6.42% |
News See All
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to Fulcrum Therapeutics Third Quarter 2023 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Fulcrum Therapeutics Second Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.
Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Ken Griffin, Skylar Capital Management, K2 Advisors, First Financial Bankshares Inc (FFIN), Deciphera Pharmaceuticals, Inc. (DCPH), and More
Pershing Square CEO Bill Ackman said Hindenburg Research’s report about Gautam Adani’s corporate empire Adani Group is "highly credible" and "extremely well-researched".
Hedge Funds Are Crazy About Fulcrum Therapeutics, Inc. (FULC)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
5 Biotech Stocks Popular On Reddit
Agenus Inc. (NASDAQ: AGEN) ranks 5th on the list of 11 biotech stocks popular on Reddit. The Massachusetts-based biotech firm develops immuno-oncology therapeutics.
Were Hedge Funds Right About Fulcrum Therapeutics, Inc. (FULC)?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Billionaire Hedge Funds
